Cambridge Cognition Holdings PLC Notice of Results (0762I)
August 25 2016 - 1:02AM
UK Regulatory
TIDMCOG
RNS Number : 0762I
Cambridge Cognition Holdings PLC
25 August 2016
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Notice of Results
The neuroscience company Cambridge Cognition Holdings PLC
(Cambridge, UK - LSE: COG), which develops and markets near patient
technologies for the assessment of brain health to improve the drug
development process, will be reporting its interim results for the
six months ended 30 June 2016 on Thursday 22 September 2016.
Enquiries:
Cambridge Cognition www.cambridgecognition.com
Holdings plc
Steven Powell, Chief Tel: 01223 810 700
Executive Officer
Nick Walters, Chief
Financial Officer
finnCap Ltd (Nomad Tel: 020 7220 0500
and Joint Broker)
Geoff Nash/Simon Hicks (Corporate Finance)
Alice Lane (Corporate Broking)
Hybridan LLP (Joint Tel: 020 3764 2341
Broker)
Claire Noyce (Corporate Broking)
About Cambridge Cognition
Cambridge Cognition is an international neuroscience company
which develops and markets near patient cognitive assessment
products to improve the understanding, diagnosis and treatment of
neurological and psychiatric disorders.
For over 30 years the company's patented technology has advanced
the assessment of cognition to accelerate the development of safe
and effective treatments, improve patient outcomes and monitor and
manage cognitive health throughout life.
Partners include the world's leading biotechnology and
pharmaceutical companies; leading academic institutions; and
public-private healthcare providers.
www.cambridgecognition.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBRGDIXBDBGLS
(END) Dow Jones Newswires
August 25, 2016 02:02 ET (06:02 GMT)
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cambridge Cognition (LSE:COG)
Historical Stock Chart
From Apr 2023 to Apr 2024